Stride: Growth At A Reasonable Price

Stride (LRN) reported outstanding FY 2025 results, with revenue up 18% and EPS up 48% year-over-year, significantly outperforming major indices. The company projects 10-15% enrollment growth for Q1, stable revenue per enrollment, and continued margin expansion at a slower pace. While Stride trades at a reasonable forward P/E of 17.34, justified by its double-digit growth expectations, investors are advised to consider waiting for a better entry point given the stock's proximity to all-time highs and potential for short-term pullbacks.

Analysis

Stride, Inc. (LRN) has reported exceptional financial results for fiscal year 2025, with revenue increasing by 18% and EPS surging by 48% year-over-year, a performance that significantly outpaces major indices. The company's forward guidance for Q1 remains robust, projecting enrollment growth between 10-15% and flat to slightly positive revenue per enrollment. While continued margin expansion is anticipated, management has indicated it will occur at a slower pace. From a valuation perspective, LRN trades at a forward P/E ratio of 17.34, which is presented as a reasonable multiple given the firm's double-digit growth trajectory. However, this strong fundamental picture is contrasted by the stock's technical position, as it currently trades near its all-time highs, introducing a risk of short-term pullbacks or consolidation.

Key Decisions for Investors

• Given the stock is trading near all-time highs, investors looking to initiate a position may consider waiting for a consolidation or pullback to find a more favorable entry point.
• Current investors could consider holding their positions to benefit from the company's strong double-digit growth and positive guidance, while remaining aware of heightened near-term volatility risk.
• Monitor Q1 enrollment figures closely to validate the company's 10-15% growth guidance, as meeting this target is critical to justifying the current valuation.